Recently described clinically important anaerobic bacteria: Medical aspects

被引:35
作者
Finegold, SM
JousimiesSomer, H
机构
[1] W LOS ANGELES VET AFFAIRS MED CTR,MICROBIAL DIS RES LAB,LOS ANGELES,CA 90073
[2] UNIV CALIF LOS ANGELES,SCH MED,DEPT MED,LOS ANGELES,CA 90024
[3] NATL PUBL HLTH INST,ANAEROBE REFERENCE LAB,HELSINKI,FINLAND
关键词
D O I
10.1086/516237
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
There is still inadequate information on the role of certain newly described or reclassified anaerobes in disease processes, on their normal sites of carriage, and on their antimicrobial susceptibilities. Herein, we summarize this information (most of the literature reviewed is from the past 5 years, but a few of the articles are similar to 10 years old). Porphyromonas species had seemed to be relatively nonpathogenic, but recent work indicates that this belief is incorrect. P. gingivalis, P. levii-like organisms, and P. endodontalis-like organisms have been recovered from a variety of oral and extraoral infections. P. macacae has been recovered from infected cat bite wounds. Sutterella wadsworthensis, recently differentiated from Campylobacter gracilis, has been found in a variety of infections. Bilophila wadsworthia has also been recovered from a wide variety of infections. Newly described anaerobic cocci, gram-positive nonsporeforming rods, and clostridia have also been isolated from various infections.
引用
收藏
页码:S88 / S93
页数:6
相关论文
共 70 条
[1]   IDENTIFICATION AND ANTIMICROBIAL RESISTANCE PATTERNS OF CLINICAL ISOLATES OF CLOSTRIDIUM-CLOSTRIDIOFORME, CLOSTRIDIUM-INNOCUUM AND CLOSTRIDIUM-RAMOSUM COMPARED WITH THOSE OF CLINICAL ISOLATES OF CLOSTRIDIUM-PERFRINGENS [J].
ALEXANDER, CJ ;
CITRON, DM ;
BRAZIER, JS ;
GOLDSTEIN, EJC .
JOURNAL OF CLINICAL MICROBIOLOGY, 1995, 33 (12) :3209-3215
[2]   Lactobacillus bacteremia: Description of the clinical course in adult patients without endocarditis [J].
Antony, SJ ;
Stratton, CW ;
Dummer, JS .
CLINICAL INFECTIOUS DISEASES, 1996, 23 (04) :773-778
[3]  
BAQUERO F, 1990, REV INFECT DIS, V12, pS157
[4]   BACTERICIDAL ACTIVITY OF SELECTED ANTIMICROBIAL AGENTS AGAINST BILOPHILA-WADSWORTHIA AND BACTEROIDES-GRACILIS [J].
BARON, EJ ;
ROPERS, G ;
SUMMANEN, P ;
COURCOL, RJ .
CLINICAL INFECTIOUS DISEASES, 1993, 16 :S339-S343
[5]  
BARON EJ, 1989, J GEN MICROBIOL, V135, P3405
[6]   BILOPHILA-WADSWORTHIA ISOLATES FROM CLINICAL SPECIMENS [J].
BARON, EJ ;
CURREN, M ;
HENDERSON, G ;
JOUSIMIESSOMER, H ;
LEE, K ;
LECHOWITZ, K ;
STRONG, CA ;
SUMMANEN, P ;
TUNER, K ;
FINEGOLD, SM .
JOURNAL OF CLINICAL MICROBIOLOGY, 1992, 30 (07) :1882-1884
[7]   RECOVERY OF UNCOMMON BACTERIA FROM BLOOD - ASSOCIATION WITH NEOPLASTIC DISEASE [J].
BEEBE, JL ;
KONEMAN, EW .
CLINICAL MICROBIOLOGY REVIEWS, 1995, 8 (03) :336-356
[8]   BILOPHILA-WADSWORTHIA BACTEREMIA IN A PATIENT WITH GANGRENOUS APPENDICITIS [J].
BERNARD, D ;
VERSCHRAEGEN, G ;
CLAEYS, G ;
LAUWERS, S ;
ROSSEEL, P .
CLINICAL INFECTIOUS DISEASES, 1994, 18 (06) :1023-1024
[9]   Taxonomy, biology, and periodontal aspects of Fusobacterium nucleatum [J].
Bolstad, AI ;
Jensen, HB ;
Bakken, V .
CLINICAL MICROBIOLOGY REVIEWS, 1996, 9 (01) :55-+
[10]   FASTIDIOUS ANAEROBE AGAR COMPARED WITH WILKINS-CHALGREN AGAR, BRAIN HEART INFUSION AGAR, AND BRUCELLA AGAR FOR SUSCEPTIBILITY TESTING OF FUSOBACTERIUM SPECIES [J].
BRAZIER, JS ;
GOLDSTEIN, EJC ;
CITRON, DM ;
OSTOVARI, MI .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1990, 34 (11) :2280-2282